137 related articles for article (PubMed ID: 17483246)
1. Two cases of cytokeratin positivity in atypical fibroxanthoma.
Bansal C; Sinkre P; Stewart D; Cockerell CJ
J Clin Pathol; 2007 Jun; 60(6):716-7. PubMed ID: 17483246
[No Abstract] [Full Text] [Related]
2. Squamous cell carcinoma detected by high-molecular-weight cytokeratin immunostaining mimicking atypical fibroxanthoma.
Gray Y; Robidoux HJ; Farrell DS; Robinson-Bostom L
Arch Pathol Lab Med; 2001 Jun; 125(6):799-802. PubMed ID: 11371235
[TBL] [Abstract][Full Text] [Related]
3. CD10, a useful marker for atypical fibroxanthomas.
Weedon D; Williamson R; Mirza B
Am J Dermatopathol; 2005 Apr; 27(2):181. PubMed ID: 15798451
[No Abstract] [Full Text] [Related]
4. Granular cell atypical fibroxanthoma: case report and review of the literature.
Wright NA; Thomas CG; Calame A; Cockerell CJ
J Cutan Pathol; 2010 Mar; 37(3):380-5. PubMed ID: 19341433
[TBL] [Abstract][Full Text] [Related]
5. Dermoscopic rainbow pattern in atypical fibroxanthoma.
Pitarch G
Actas Dermosifiliogr; 2014; 105(1):97-9. PubMed ID: 23489998
[No Abstract] [Full Text] [Related]
6. Localized cutaneous metastases from an atypical fibroxanthoma.
Giuffrida TJ; Kligora CJ; Goldstein GD
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
[TBL] [Abstract][Full Text] [Related]
7. h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.
Martinez-Ciarpaglini C; Agustí J; Alvarez E; Hueso L; Terrádez L; Monteagudo C
Pathology; 2018 Apr; 50(3):358-361. PubMed ID: 29490873
[No Abstract] [Full Text] [Related]
8. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
9. Pigmented atypical fibroxanthoma.
Diaz-Cascajo C; Borghi S; Bonczkowitz M
Histopathology; 1998 Dec; 33(6):537-41. PubMed ID: 9870148
[TBL] [Abstract][Full Text] [Related]
10. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
11. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
Cai JP; Randall B
J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
[No Abstract] [Full Text] [Related]
12. Atypical fibroxanthoma with granular cells.
Orosz Z
Histopathology; 1998 Jul; 33(1):88-9. PubMed ID: 9726059
[No Abstract] [Full Text] [Related]
13. Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy.
Koch M; Freundl AJ; Agaimy A; Kiesewetter F; Künzel J; Cicha I; Alexiou C
Anticancer Res; 2015 Nov; 35(11):5717-35. PubMed ID: 26503993
[TBL] [Abstract][Full Text] [Related]
14. Red is dead.
McCalmont TH
J Cutan Pathol; 2012 Mar; 39(3):315-6. PubMed ID: 22335589
[No Abstract] [Full Text] [Related]
15. Test and Teach. Number Ninety: Part 1. Plexiform fibrohistiocytic tumor.
Ng WK; Hlaing TT
Pathology; 1998 Aug; 30(3):257-8, 314-5. PubMed ID: 9770189
[No Abstract] [Full Text] [Related]
16. [Malignant histiocytofibroma. Apropos of 3 cases of cervicofacial localization].
Bonnin P; Lallemant JG; Chapuis H; Roumieux JL; Irolla E; Robert M
Ann Otolaryngol Chir Cervicofac; 1995; 112(7):336-44. PubMed ID: 8745701
[TBL] [Abstract][Full Text] [Related]
17. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of atypical fibroxanthoma.
Farley R; Ratner D
Skinmed; 2006; 5(2):83-6. PubMed ID: 16603840
[TBL] [Abstract][Full Text] [Related]
19. Aberrant S100 expression in cutaneous malignant fibrous histiocytoma: a potential pitfall in diagnosis.
Gulmann C; Egan B; Cottell D; Keane FB; Jeffers MD
Histopathology; 2002 Oct; 41(4):363-4. PubMed ID: 12383220
[No Abstract] [Full Text] [Related]
20. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
